Black women may be less likely to receive timely treatment for breast cancer

September 21, 2020

New research suggests that Black women experience longer waits for treatment initiation than white women after a breast cancer diagnosis, and their duration of treatment is prolonged. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society (ACS).

Previous research has shown that Black women face a higher risk of dying from breast cancer than white women despite similar rates of breast cancer occurrence, and this disparity is especially high among younger women. A team led by Melissa A. Troester, PhD, of the University of North Carolina at Chapel Hill (UNC) and UNC Lineberger Comprehensive Cancer Center evaluated whether two aspects of care--time to treatment and duration of treatment--may be contributing factors.

The investigators' analysis included 2,841 participants (roughly equal numbers of Black and white women) with stage I-III breast cancer in the Carolina Breast Cancer Study, a population-based study of women with invasive breast cancer.

The overall median time to treatment initiation was 34 days. More Black women experienced a delayed time to treatment (13.4 percent versus 7.9 percent) and a prolonged duration of treatment (29.9 percent versus 21.1 percent) compared with white women.

Thirty-two percent of young Black women were in the highest quartile of treatment duration, compared with 22.3 percent of younger white women; similarly, 27.9 percent of older Black women experienced prolonged treatment duration compared with 19.9 percent of older white women.

Also, among women with high socioeconomic status, 11.7 percent of Black women experienced delays in initiating treatment compared with 6.7 percent of white women.

"Even among women with low socioeconomic status, we still saw fewer delays among white women, underscoring the disparate experience of Black women, who appear to experience unique barriers," said lead author Marc Emerson, PhD.

"It is important to recognize that the causes of delay are complex and reflect both individual barriers and system level factors," Dr. Troester added. The study identified a number of specific barriers, including financial and transportation issues.
-end-
Additional Information

NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the Cancer News Room upon online publication.

For more information or to obtain a PDF of any study, please contact:

Dawn Peters +1 781-388-8408 (US)
newsroom@wiley.com

Follow us on Twitter @WileyNews

Full Citation:

"Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women." Marc A. Emerson, Yvonne M. Golightly, Allison E. Aiello, Katherine E. Reeder-Hayes, Xianming Tan, Ugwuji Maduekwe, Marian Johnson- Thompson, Andrew F. Olshan, and Melissa A. Troester. Cancer; Published Online: September 21, 2020 (DOI: 10.1002/cncr.33121).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.33121

Author Contact: Bill Schaller, of the UNC Lineberger Communications office, at bill_schaller@med.unc.edu or +1 617-233-5507.

About the Journal

Cancer is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of Cancer is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. Cancer is published on behalf of the American Cancer Society by Wiley and can be accessed online.

Follow us on Twitter @JournalCancer

About Wiley

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at http://www.wiley.com.

Wiley

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.